- Home
- CADL vs FLYX Comparison
CADL vs FLYX Comparison
Compare CADL & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- FLYX
- Stock Information
- Founded
- CADL 1999
- FLYX 2015
- Country
- CADL United States
- FLYX United States
- Employees
- CADL N/A
- FLYX N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- FLYX Blank Checks
- Sector
- CADL Health Care
- FLYX Finance
- Exchange
- CADL Nasdaq
- FLYX Nasdaq
- Market Cap
- CADL 306.4M
- FLYX 264.1M
- IPO Year
- CADL 2021
- FLYX N/A
- Fundamental
- Price
- CADL $8.09
- FLYX $3.13
- Analyst Decision
- CADL Strong Buy
- FLYX
- Analyst Count
- CADL 4
- FLYX 0
- Target Price
- CADL $21.00
- FLYX N/A
- AVG Volume (30 Days)
- CADL 918.0K
- FLYX 13.1K
- Earning Date
- CADL 03-13-2025
- FLYX 01-01-0001
- Dividend Yield
- CADL N/A
- FLYX N/A
- EPS Growth
- CADL N/A
- FLYX N/A
- EPS
- CADL N/A
- FLYX N/A
- Revenue
- CADL N/A
- FLYX $327,274,000.00
- Revenue This Year
- CADL N/A
- FLYX $4.63
- Revenue Next Year
- CADL N/A
- FLYX $33.97
- P/E Ratio
- CADL N/A
- FLYX N/A
- Revenue Growth
- CADL N/A
- FLYX N/A
- 52 Week Low
- CADL $1.45
- FLYX $1.79
- 52 Week High
- CADL $14.60
- FLYX $10.46
- Technical
- Relative Strength Index (RSI)
- CADL 49.50
- FLYX 46.68
- Support Level
- CADL $7.85
- FLYX $3.00
- Resistance Level
- CADL $8.69
- FLYX $3.53
- Average True Range (ATR)
- CADL 0.54
- FLYX 0.26
- MACD
- CADL -0.02
- FLYX 0.01
- Stochastic Oscillator
- CADL 54.55
- FLYX 24.53
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.